Advertisement

Picture [iito] Made Without Love 650x80px
Product › Details

mRNA-based vaccine

Products Next higher product group vaccine
     

CureVac AG. (12/22/17). "Press Release: CureVac to Present at the 2018 J.P. Morgan 36th Annual Healthcare Conference". Tübingen & Boston, MA.

CureVac to Present at the 2018 J.P. Morgan 36th Annual Healthcare Conference


CureVac AG, a clinical-stage biopharmaceutical company pioneering mRNA-based drugs, will present at the 2018 J.P. Morgan 36th Annual Healthcare Conference to be held January 8-12, 2018 at the Westin St. Francis Hotel in San Francisco, CA. The presentation will be delivered by Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac AG.

Details of CureVac's presentation are as follows:

Event: J.P. Morgan 36th Annual Healthcare Conference
Date: January 10, 2018
Time: 8:00 – 8:25 AM (Pacific Time) / 5:00 - 5:25 PM (Eastern Standard Time)

A live webcast of the presentation will be available here for replay following the event.

Further information on the 2018 J.P. Morgan 36th Annual Healthcare Conference can be found here.


Your contact

Verena Lauterbach
Senior Manager Communications
T: +49 7071 9883 1756
contact via e-mail

   
Record changed: 2021-06-07

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for mRNA-based vaccine


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top